Xortx Therapeutics logo

Xortx Therapeutics Share Price (NASDAQ: XRTX)

$0.81

0.01

(1.25%)

Live

Last updated on

Check the interactive Xortx Therapeutics Stock chart to analyse performance

Xortx Therapeutics stock performance

as on August 23, 2025 at 12:27 AM IST

  • Today's Low:$0.81
    Today's High:$0.82

    Day's Volatility :1.22%

  • 52 Weeks Low:$0.66
    52 Weeks High:$2.98

    52 Weeks Volatility :77.82%

Xortx Therapeutics Stock Returns

PeriodXortx Therapeutics IncIndex (Russel 2000)
3 Months
-12.73%
0.0%
6 Months
1.22%
0.0%
1 Year
-31.4%
0.0%
3 Years
-53.63%
-7.7%

Xortx Therapeutics Inc Key Stats

Check Xortx Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.8
Open
$0.715
Today's High
$0.82
Today's Low
$0.81
Market Capitalization
$3.9M
Today's Volume
$157.5K
52 Week High
$2.9799
52 Week Low
$0.6608
Revenue TTM
$0.0
EBITDA
$-2.6M
Earnings Per Share (EPS)
$-0.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.97%
Return On Equity TTM
-79.44%

Stock Returns calculator for Xortx Therapeutics Stock including INR - Dollar returns

The Xortx Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xortx Therapeutics investment value today

Current value as on today

₹71,223

Returns

₹28,777

(-28.78%)

Returns from Xortx Therapeutics Stock

₹33,058 (-33.06%)

Dollar Returns*

₹4,281 (+4.28%)

Indian investors sentiment towards Xortx Therapeutics Stock

-29%

Period: Jul 22, 2025 to Aug 21, 2025. Change in 30 Days versus previous period

Search interest for Xortx Therapeutics Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Xortx Therapeutics Inc

  • Name

    Holdings %

  • Hartland & Co

    0.01%

Analyst Recommendation on Xortx Therapeutics Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Xortx Therapeutics(by analysts ranked 0 to 5 stars)

Xortx Therapeutics Share Price Target

What analysts predicted

Upside of 1681.91%

Target:

$14.43

Current:

$0.81

Xortx Therapeutics share price target is $14.43, a slight Upside of 1681.91% compared to current price of $0.81 as per analysts' prediction.

Xortx Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, XRTX stock has moved down by -17.0%
  • XRTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 99.7%
  • XRTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 114.2% return, outperforming this stock by 163.9%

Xortx Therapeutics Technicals Summary

Sell

Neutral

Buy

Xortx Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Xortx Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Xortx Therapeutics Inc logo
-7.79%
1.22%
-31.4%
-53.63%
-73.57%
Regeneron Pharmaceuticals, Inc. logo
4.5%
-14.59%
-49.64%
-0.73%
0.56%
Beone Medicines Ltd logo
6.48%
22.93%
60.47%
81.44%
32.24%
Vertex Pharmaceuticals Incorporated logo
-16.69%
-17.94%
-17.2%
38.81%
48.58%
Alnylam Pharmaceuticals, Inc. logo
43.34%
86.27%
68.31%
115.22%
254.29%

About Xortx Therapeutics Inc

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.
Organization
Xortx Therapeutics
Employees
0
CEO
Dr. Allen Warren Davidoff Ph.D.
Industry
Miscellaneous

Key Management of Xortx Therapeutics Inc

NameTitle
Dr. Allen Warren Davidoff Ph.D.
Founder, CEO, President & Director
Dr. Michael Scott Bumby D.V.M., M.B.A.
Chief Financial Officer
Dr. Stephen Haworth M.D., MRCP
Chief Medical Officer
Dr. Stacy Evans M.B.A., M.D.
Chief Business Officer
Nick Rigopoulos
Director of Communications
Dr. David Sans M.B.A., Ph.D.
Director of Corporate Development
Dr. David MacDonald Ph.D.
Consultant of Clinical Operations
Ms. Charlotte May
Corporate Secretary

Important FAQs about investing in XRTX Stock from India :

What is Xortx Therapeutics share price today?

Xortx Therapeutics share price today is $0.81 as on . Xortx Therapeutics share today touched a day high of $0.82 and a low of $0.81.

What is the 52 week high and 52 week low for Xortx Therapeutics share?

Xortx Therapeutics share touched a 52 week high of $2.98 and a 52 week low of $0.66. Xortx Therapeutics stock price today i.e. is trending at $0.81, lower by 72.82% versus the 52 week high.

How to invest in Xortx Therapeutics Stock (XRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xortx Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xortx Therapeutics Shares that will get you 1.8519 shares as per Xortx Therapeutics share price of $0.81 per share as on August 23, 2025 at 12:27 AM IST.

What is the minimum amount required to buy Xortx Therapeutics Stock (XRTX) from India?

Indian investors can start investing in Xortx Therapeutics (XRTX) shares with as little as ₹87.521 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Xortx Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 22, 2025). Based on Xortx Therapeutics share’s latest price of $0.81 as on August 23, 2025 at 12:27 AM IST, you will get 12.3457 shares of Xortx Therapeutics. Learn more about fractional shares .

What are the returns that Xortx Therapeutics has given to Indian investors in the last 5 years?

Xortx Therapeutics stock has given -73.57% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?